- $42.6 BnWorld market, 2023
- $75.6 BnProjected, 2033
- 5.9%Growth a year (CAGR)
- 941Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$17.9 Bn
3.9% a year · 42% of the world -
2
China
$3.4 Bn
7.4% a year · 8% of the world -
3
Canada
$3.4 Bn
5.9% a year · 8% of the world -
4
Japan
$2.6 Bn
6.4% a year · 6.2% of the world -
5
Germany
$1.6 Bn
4.1% a year · 3.7% of the world -
6
France
$1.2 Bn
4.9% a year · 2.8% of the world -
7
UK
$1.1 Bn
3.9% a year · 2.6% of the world -
8
Brazil
$1.1 Bn
6.9% a year · 2.5% of the world -
9
Italy
$1 Bn
5.4% a year · 2.4% of the world -
10
Ecuador
$852 Mn
6.5% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainDiabetes Care Devices by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 8,419 papers since 2021
- Advances in the hospital management of hyperglycemia and type 2 diabetes in non-critical care settings. BMJ open diabetes research & care, 2026
- Continuous Glucose Monitoring in Obesity Without Diabetes: An Unnecessary Gadget or a Gateway to Precision Care? Diabetes, obesity & metabolism, 2026
- Clinical Outcomes of Multidisciplinary Remote Patient Monitoring for Patients With Poorly Controlled Type 2 Diabetes: Retrospective Cohort Study. JMIR diabetes, 2026
- Caregiver Perceptions of Blood Glucose Monitoring in Children and Adolescents Living With Type 1 Diabetes in Kyrgyzstan, Mali, Tanzania, and Peru: Qualitative Study. JMIR diabetes, 2026
- Guiding Inpatient Glycemic Management with Continuous Glucose Monitoring. A Prospective Nonrandomized Comparative Cohort Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Patients: Diabetes (adults)
| Place | Value | Year |
|---|---|---|
| World | 14.1 | 2022 |
| Australia | 8.1 | 2022 |
| Brazil | 12.9 | 2022 |
| Canada | 6.8 | 2022 |
| China | 11.2 | 2022 |
| Ecuador | 12.7 | 2022 |
| Egypt | 27.8 | 2022 |
| France | 2.7 | 2022 |
| Germany | 6.6 | 2022 |
| India | 22.6 | 2022 |
| Italy | 7.2 | 2022 |
| Japan | 6.4 | 2022 |
| Kenya | 5.6 | 2022 |
| Malaysia | 26.7 | 2022 |
| Mexico | 14.3 | 2022 |
| New Zealand | 9.0 | 2022 |
| Philippines | 13.2 | 2022 |
| Russia | 8.1 | 2022 |
| Saudi Arabia | 20.8 | 2022 |
| Singapore | 13.1 | 2022 |
| South Africa | 13.9 | 2022 |
| Spain | 3.6 | 2022 |
| Thailand | 12.3 | 2022 |
| UAE | 26.1 | 2022 |
| UK | 8.8 | 2022 |
| US | 12.5 | 2022 |
Compare Diabetes Care Devices side by side
Key companies in Diabetes Care Devices
Medtronic plc
Abbott Laboratories
Dexcom, Inc.
Roche Diabetes Care
Novo Nordisk A/S
Ascensia Diabetes Care Holdings AS
LifeScan, Inc.
AgaMatrix Holdings LLC
Insulet Corporation
Bionime Corporation
Quick answers
How big is the Diabetes Care Devices market?
The world Diabetes Care Devices market was worth about $42.6 Bn in 2023 and is projected to reach $75.6 Bn by 2033, growing 5.9% a year (CAGR).
Which country has the largest Diabetes Care Devices market?
The US is the largest of the 24 countries we cover, at $17.9 Bn in 2023. India grows fastest, at 8.9% a year.
How many clinical trials are running in Diabetes Care Devices?
ClinicalTrials.gov lists 941 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Diabetes Care Devices?
PubMed lists about 8,419 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.